Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | KLK7 | P49862 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21305326 | 0.86 | HTT (0.40) | KMT2AKLK7HTTSMN1; SMN2LMNA | |
| SCHEMBL21307659 | 0.82 | ALDH1A1 (0.45) | KMT2AKLK7HTTSMN1; SMN2NPSR1 | |
| SCHEMBL16093068 | 0.82 | KMT2A (0.50) | KMT2AKLK7HTTPTGS1PTGS2 | |
| SCHEMBL237873 | 0.80 | KMT2A (0.51) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 | |
| SCHEMBL2893483 | 0.80 | KMT2A (0.51) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 | |
| Propane SCHEMBL3346178 | 0.77 | KMT2A (0.47) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 | |
| SCHEMBL283611 | 0.76 | KMT2A (0.62) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 | |
| SCHEMBL13305881 | 0.75 | KMT2A (0.46) | KMT2AHTTPTGS1PTGS2SMN1; SMN2 | |
| SCHEMBL13305895 | 0.75 | KMT2A (0.46) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 | |
| SCHEMBL16841424 | 0.75 | KMT2A (0.53) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1400508-B1 | Dithiocarbamic acid ester | LANXESS DEUTSCHLAND GMBH (DE) | 2014-12-24 | — | — | EP | disclosed |
| US-7977431-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2011-07-12 | — | — | US | disclosed |
| US-7977431-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2011-07-12 | — | — | US | disclosed |
| US-20110015360-A1 | DITHIOCARBAMIC ESTERS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| US-20110015360-A1 | DITHIOCARBAMIC ESTERS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| US-7825193-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2010-11-02 | — | — | US | disclosed |
| US-7825193-B2 | Dithiocarbamic esters | LANXESS DEUTSCHLAND GMBH (DE) | 2010-11-02 | — | — | US | disclosed |
| US-20070078229-A1 | suitable for regulating the molecular weight during the polymerization of chloroprene and/or 2,3-dichlorobutadiene; compound purity; no sacrifice of polymerization rate; efficient; industrial scale | ARLANXEO DEUTSCHLAND GMBH (DE) | 2007-04-05 | — | — | US | disclosed |
| US-20070078229-A1 | suitable for regulating the molecular weight during the polymerization of chloroprene and/or 2,3-dichlorobutadiene; compound purity; no sacrifice of polymerization rate; efficient; industrial scale | ARLANXEO DEUTSCHLAND GMBH (DE) | 2007-04-05 | — | — | US | disclosed |
| US-7169937-B2 | Dithiocarbamic esters | BAYER AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-7169937-B2 | Dithiocarbamic esters | BAYER AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078229-A1 | suitable for regulating the molecular weight during the polymerization of chloroprene and/or 2,3-dichlorobutadiene; compound purity; no sacrifice of polymerization rate; efficient; industrial scale | DDT, DHPS, CBR3 | KMT2A 2686/4885KLK7 4033/4885HTT 3932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.